NHRI sees progress in COVID-19 vaccine, human trials likely this year

Promising results have been seen in research on a DNA vaccine against the SARS-CoV-2 (COVID-19) virus, with human trials likely to commence later this year, Taiwan's National Health Research Institutes (NHRI) said Monday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)